Levesialle Continu (Ethinylestradiol, Levonorgestrel | Lactose)

Ethinyloestradiol acts as an estrogen component that binds to estrogen receptors, helping to suppress the release of luteinizing hormone and follicle‑stimulating hormone. This suppression, together with the progestogenic action of levonorgestrel, prevents ovulation and creates cervical mucus and endometrial changes that hinder fertilisation and implantation.

The dosing regimen for Levesialle Continu is determined by the prescribing healthcare professional. Typically, combined oral contraceptives are taken once daily for a specified cycle, but the exact schedule, tablet strength, and duration should follow the prescriber’s instructions.

Levesialle Continu is contraindicated during pregnancy; it should be stopped immediately if pregnancy is confirmed. While limited data exist for breastfeeding, the decision to use hormonal contraception while nursing should be made by a healthcare provider, weighing potential benefits and risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Levesialle Continu contains the standard dose combination of ethinyloestradiol and levonorgestrel, similar to many other combined oral contraceptives. Its efficacy, safety profile, and side‑effect spectrum are comparable to other products in the same class, with differences mainly in tablet formulation, packaging, and regulatory approvals.

Store Levesialle Continu tablets at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect from moisture and direct sunlight, and retain the tablets in their original packaging until use.

Levesialle Continu is taken orally, usually once daily at the same time each day. The tablet is swallowed whole with water and should be started according to the prescriber’s schedule, often on the first day of the menstrual period or as directed.

Serious risks include venous thromboembolism (such as deep‑vein thrombosis or pulmonary embolism), severe hypertension, and rare cases of hepatic adenoma. Patients should seek immediate medical attention if they experience unexplained leg pain, shortness of breath, severe headache, or sudden high blood pressure.

Women with a history of thromboembolic disorders, uncontrolled hypertension, certain hormone‑dependent cancers, active liver disease, or who are smokers over the age of 35 should avoid using Levesialle Continu. Additionally, it is contraindicated during pregnancy and in individuals with known hypersensitivity to any component of the tablet.